MedTrace Logo

Assessing the Efficacy of Steroid Treatment of Achalasia

NCT01903486 · Status: WITHDRAWN · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2021-11-17

No results posted yet for this study

Summary

Would systemic steroids be an effective treatment in early variants of achalasia?

Conditions

  • Achalasia

Interventions

DRUG

Apo-Prednisone Cordorol, Detasone - Prednisone

Oral prednisone (study medication) at a dose of 40mg for 1 week, then 30mg for 1 week, then 20mg for 1 week, then 10mg for 1 week, and then stop the medication.

Sponsors & Collaborators

Principal Investigators

  • Karthik Ravi, MD · Mayo Clinic

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-03-31
Primary Completion
2020-12-28
Completion
2020-12-28
FDA Drug
Yes

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01903486 on ClinicalTrials.gov